General MedicationsORALStandard
HYDROCODONE BITARTRATE
HYDROCODONE BITARTRATE
Standard Dose
100MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary
Approval overview HYDROCODONE BITARTRATE is listed in Drugs@FDA under application 208269 (ANDA).
Marketing status: Prescription Active ingredient HYDROCODONE BITARTRATE Form and strength TABLET, EXTENDED RELEASE;ORAL - 100MG Sponsor ALVOGEN Submission history Latest submission status date: 2024-10-31 00:00:00.
Structured Monograph
Clinical summary
Approval overview HYDROCODONE BITARTRATE is listed in Drugs@FDA under application 208269 (ANDA). Marketing status: Prescription Active ingredient HYDROCODONE BITARTRATE Form and strength TABLET, EXTENDED RELEASE;ORAL - 100MG Sponsor ALVOGEN Submission history Latest submission status date: 2024-10-31 00:00:00. Submission type: SUPPL.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Prescription
Interaction Notes
- No interaction notes stored yet.